A Clinical Trial on Sequential Immunization of Recombinant COVID-19 Vaccine (CHO Cell, NVSI-06-09) and Inactivated COVID-19 Vaccine (Vero Cell)
Clinical trial NCT05293548 · UNKNOWN
Trial details
- NCT number
- NCT05293548
- Sponsor
- National Vaccine and Serum Institute, China
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-25
- Primary completion
- 2023-05-01
- Enrollment
- 516
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.